Aldeyra Therapeutics, Inc. (ALDX)
NASDAQ: ALDX · Real-Time Price · USD
6.69
-0.03 (-0.45%)
At close: Feb 21, 2025, 4:00 PM
6.80
+0.11 (1.64%)
After-hours: Feb 21, 2025, 4:33 PM EST
Aldeyra Therapeutics Market Cap
Aldeyra Therapeutics has a market cap or net worth of $398.39 million as of February 21, 2025. Its market cap has increased by 102.74% in one year.
Market Cap
398.39M
Enterprise Value
341.26M
1-Year Change
102.74%
Ranking
Category
Stock Price
$6.69
Market Cap Chart
Since May 2, 2014, Aldeyra Therapeutics's market cap has increased from $37.20M to $398.39M, an increase of 970.93%. That is a compound annual growth rate of 24.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 398.40M | 34.05% |
| Dec 31, 2024 | 297.20M | 43.92% |
| Dec 29, 2023 | 206.50M | -49.34% |
| Dec 30, 2022 | 407.60M | 75.39% |
| Dec 31, 2021 | 232.40M | -12.73% |
| Dec 31, 2020 | 266.30M | 63.98% |
| Dec 31, 2019 | 162.40M | -25.44% |
| Dec 31, 2018 | 217.80M | 67.54% |
| Dec 29, 2017 | 130.00M | 93.16% |
| Dec 30, 2016 | 67.30M | 2.12% |
| Dec 31, 2015 | 65.90M | 63.93% |
| Dec 31, 2014 | 40.20M | 8.06% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |